BaguleyIJ, PerkesIE, Fernandez-OrtegaJF, et al.Paroxysmal sympathetic hyperactivity after acquired brain injury: Consensus on conceptual definition, nomenclature, and diagnostic criteria. J Neurotrauma, 2014; 31(17):1515–1520; doi: 10.1089/neu.2013.3301
2.
PerkesI, BaguleyIJ, NottMT, et al.A review of paroxysmal sympathetic hyperactivity after acquired brain injury. Ann Neurol, 2010; 68(2):126–135; doi: 10.1002/ana.22066
3.
LevyER, McVeighU, RamsayAM. Paroxysmal sympathetic hyperactivity (sympathetic storm) in a patient with permanent vegetative state. J Palliat Med, 2011; 14(12):1355–1357; doi: 10.1089/jpm.2010.0444
HughesJD, RabinsteinAA. Early diagnosis of paroxysmal sympathetic hyperactivity in the ICU. Neurocrit Care, 2014; 20(3):454–459; doi: 10.1007/s12028-013-9877-3
8.
MathewMJ, DeepikaA, ShuklaD, et al.Paroxysmal sympathetic hyperactivity in severe traumatic brain injury. Acta Neurochir (Wien), 2016; 158(11):2047–2052; doi: 10.1007/s00701-016-2934-x
9.
ThomasA, GreenwaldBD. Paroxysmal sympathetic hyperactivity and clinical considerations for patients with acquired brain injuries: A narrative review. Am J Phys Med Rehabil, 2019; 98(1):65–72; doi: 10.1097/PHM.0000000000000990
10.
SamuelS, AllisonTA, LeeK, et al.Pharmacologic management of paroxysmal sympathetic hyperactivity after brain injury. J Neurosci Nurs, 2016; 48(2):82–89; doi: 10.1097/JNN.0000000000000207
11.
CidE, MellaF, LucchiniL, et al.Plasma concentrations and bioavailability of propranolol by oral, rectal, and intravenous administration in man. Biopharm Drug Dispos, 1986; 7(6):559–566.
ZhengRZ, LeiZQ, YangRZ, et al.Identification and management of paroxysmal sympathetic hyperactivity after traumatic brain injury. Front Neurol, 2020; 11;81; doi: 10.3389/fneur.2020.00081
